EXHIBIT 11
CURAGEN CORPORATION AND SUBSIDIARY
COMPUTATION OF NET LOSS PER SHARE
(unaudited)
| |
|
Three Months Ended
September 30,
|
|
Nine Months Ended
September 30,
|
| |
|
2000
|
|
1999
|
|
2000
|
|
1999
|
Net loss before income taxes and minority
interest |
|
$ (7,274,807 |
) |
|
$ (5,147,393 |
) |
|
$(18,927,158 |
) |
|
$(18,279,463 |
) |
| Income tax benefit |
|
270,000 |
|
|
— |
|
|
620,000 |
|
|
— |
|
| Minority interest |
|
(46,235 |
) |
|
— |
|
|
(64,470 |
) |
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
$ (7,051,042 |
) |
|
$ (5,147,393 |
) |
|
$(18,371,628 |
) |
|
$(18,279,463 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Basic and diluted net loss per share |
|
$ (0.18 |
) |
|
$ (0.18 |
) |
|
$ (0.49 |
) |
|
$ (0.67 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares used in
computing basic and diluted net loss per
share |
|
38,743,862 |
|
|
27,996,724 |
|
|
37,749,099 |
|
|
27,229,670 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
